Seventy percent of oncology-related deaths are due to cancers without a recommended screening test. Intercepting cancer in its earliest and most treatable form is crucial to maximizing recovery chances for those fighting this disease in its many forms.

The Texas Cancer Interception Institute (TCII) at Baylor Scott & White Health is a pioneering initiative dedicated to detecting and treating cancer earlier than ever before. Baylor Scott & White Irving Foundation is excited to partner with visionary donors who want to support innovative new approaches and technology that makes early detection possible.

With national efforts to reduce cancer mortality by 50 percent in 25 years, TCII supports this goal by shifting cancer care from a reactive model to a proactive, interception-based approach. By bringing together patient navigation with the latest innovations in genomic sequencing, biomarker research and AI-driven diagnostics, TCII is changing the way we detect and treat cancer.

Want to help us detect cancers earlier than ever before? Scan this code to make a gift securely today and to learn more.